Amyotrophic Lateral Sclerosis
- 1 January 2003
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 63 (3), 289-310
- https://doi.org/10.2165/00003495-200363030-00004
Abstract
No abstract availableKeywords
This publication has 237 references indexed in Scilit:
- Therapeutic benefit of polyamine-modified catalase as a scavenger of hydrogen peroxide and nitric oxide in familial amyotrophic lateral sclerosis transgenicsAnnals of Neurology, 2000
- A Specific Inhibitor of Janus Kinase-3 Increases Survival in a Transgenic Mouse Model of Amyotrophic Lateral SclerosisBiochemical and Biophysical Research Communications, 2000
- Therapeutic Benefits of Putrescine-Modified Catalase in a Transgenic Mouse Model of Familial Amyotrophic Lateral SclerosisExperimental Neurology, 1999
- The effect of the nonpeptide neurotrophic compound SR 57746A on the progression of the disease state of the pmn mouseBritish Journal of Pharmacology, 1998
- Stability of Mutant Superoxide Dismutase-1 Associated with Familial Amyotrophic Lateral Sclerosis Determines the Manner of Copper Release and Induction of Thioredoxin in ErythrocytesBiochemical and Biophysical Research Communications, 1997
- Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortexAnnals of Neurology, 1996
- Works in progress abstractsAnnals of Neurology, 1995
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994
- Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiationAnnals of Neurology, 1994
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993